Cargando…

Case Report: A Metabolic Complete Response to Upfront Osimertinib in a Smoker Non-Small Cell Lung Cancer Patient Harbouring EGFR G719A/V769M Complex Mutation

Complex EGFR mutations are rare in non-small cell lung cancer (NSCLC). Limited clinical evidence is available on the efficacy of EGFR tyrosine kinase inhibitors (TKIs) in patients with NSCLC harbouring these uncommon EGFR mutations. Here, we reported the case of a complete metabolic response in a pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Simionato, Francesca, Calvetti, Lorenzo, Cosci, Marco, Scarparo, Silvia, Aprile, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695685/
https://www.ncbi.nlm.nih.gov/pubmed/33262603
http://dx.doi.org/10.2147/OTT.S280933